FDA

Better oversight is needed of the “biohacking” that individuals perform on themselves.

A recent FDA proposed rule would transform over-the-counter sunscreen regulation.

Upcoming FDA hearing could set the course for regulatory approval of the burgeoning CBD industry.

Former Commissioner Scott Gottlieb recently discussed the e-cigarette epidemic among American youth.

The permissive drug approval process enabled by the 21st Century Cures Act may cause public health problems.

Experts offer solutions to pressing issues in American health care.

Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.

Plant-based milk producers may soon no longer be able to put “milk” on their labels.

FDA and USDA’s plan to jointly regulate lab-made meat raises new questions for the future of food regulation.

Scholar argues FDA should regulate insects as food to help address food insecurity.

Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.

Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.